NEWS
/
/
/
Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2022-06-11
  • Views:0

(Summary description)Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.

Good news || High quality Betadex Sulfobutyl Ether Sodium prompt the approval and marketing of Voriconazole for injection

(Summary description)Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2022-06-11
  • Views:0
Information

  Nowadays Voriconazole for injection by Poly Pharm has been approved by the NMPA officially.

  Voriconazole for injection is the second approved preparation by NMPA with our excipient in China. Betadex Sulfobutyl Ether Sodium, a new pharmaceutical excipient, is the key excipient of Voriconazole for injection. Zibo Qianhui initiated research and development from 2013, and the registration status in CDE turned to "A" in 2021.

  Appreciating the trust and support of many customers, Betadex Sulfobutyl Ether Sodium of Qianhui is the only product that has been turned to "A" through associated review in China. Moreover, our product has also been registered in FDA and applied for CEP certificate. Product quality meets the requirements of USP and EP with manufacturing process follows GMP strictly.

Scan the QR code to read on your phone

MORE NEWS

Contact Us

Username used for comment:
客户留言
Description:
验证码

COPYRIGHT © 2021 Zibo Qianhui Biological Technology Co., Ltd.   鲁ICP备16006179号-6  Powered by 300.cn 

EWM

How can I help you?

0086-533-3780067